These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27745574)

  • 41. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A clinical hepatologist's predictions about non-absorbed carbohydrates for the early twenty-first century.
    Conn HO
    Scand J Gastroenterol Suppl; 1997; 222():88-92. PubMed ID: 9145456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lactulose a day keeps encephalopathy at bay.
    Klinken E; MacQuillan G
    J Gastroenterol Hepatol; 2011 Jun; 26(6):939-40. PubMed ID: 21564285
    [No Abstract]   [Full Text] [Related]  

  • 46. Gut flora and hepatic encephalopathy in patients with cirrhosis.
    Riordan SM; Williams R
    N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
    [No Abstract]   [Full Text] [Related]  

  • 47. 'Hepatic' encephalopathy because of spontaneous mesenterico-caval shunt.
    Colle I; De Keukeleire K; Pauwels W; Van Vlierberghe H
    Liver Int; 2008 Aug; 28(7):982. PubMed ID: 18783542
    [No Abstract]   [Full Text] [Related]  

  • 48. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Agrawal A; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lactulose, disaccharides and colonic flora. Clinical consequences.
    Clausen MR; Mortensen PB
    Drugs; 1997 Jun; 53(6):930-42. PubMed ID: 9179525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hepatic encephalopathy – the acute management].
    Wahlin S
    Lakartidningen; 2016 Mar; 113():. PubMed ID: 26978809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyethylene Glycol Versus Lactulose for Hepatic Encephalopathy: Do We Have a Clear Winner?
    Giri S
    J Clin Gastroenterol; 2022 Feb; 56(2):192. PubMed ID: 35104256
    [No Abstract]   [Full Text] [Related]  

  • 55. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
    Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
    Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rifaximin treatment in hepatic encephalopathy.
    Sharma P; Sharma BC
    N Engl J Med; 2010 Jun; 362(25):2423-4; author reply 2424-5. PubMed ID: 20578274
    [No Abstract]   [Full Text] [Related]  

  • 57. Medical, nutritional and technological properties of lactulose. An update.
    Schumann C
    Eur J Nutr; 2002 Nov; 41 Suppl 1():I17-25. PubMed ID: 12420112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Health Care Burden of Hepatic Encephalopathy.
    Elsaid MI; John T; Li Y; Pentakota SR; Rustgi VK
    Clin Liver Dis; 2020 May; 24(2):263-275. PubMed ID: 32245532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lactulose for hepatic encephalopathy.
    Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.